The year's new drugs.
Forty-one new biological drugs and diagnostic agents reached their first markets in 2005. Antiinfective therapy, immunomodulators and agents for immunization and central nervous system drugs were the most active therapeutic groups in terms of new chemical entities launched for the first time, with six market introductions apiece. The United States was again the most active market for new products, with a total of 21 new launches in 2005, constituting 50% of the total of new introductions for the year.